We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+6.19%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$10.7B
AUM Growth
+$2.52B
Cap. Flow
+$2.21B
Cap. Flow %
20.71%
Top 10 Hldgs %
17.42%
Holding
1,276
New
389
Increased
311
Reduced
230
Closed
325

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$119M
2
PRGO icon
Perrigo
PRGO
+$108M
3
MSFT icon
Microsoft
MSFT
+$107M
4
ZTS icon
Zoetis
ZTS
+$84.7M
5
VTRS icon
Viatris
VTRS
+$78.7M

Top Sells

Rank Stock Value
1
SHW icon
Sherwin-Williams
SHW
+$73.7M
2
JNJ icon
Johnson & Johnson
JNJ
+$67.8M
3
META icon
Meta Platforms (Facebook)
META
+$66.6M
4
NKE icon
Nike
NKE
+$57.9M
5
AZO icon
AutoZone
AZO
+$54.1M

Sector Composition

Rank Sector Weight
1 Healthcare 22.92%
2 Communication Services 13.85%
3 Financials 12.23%
4 Industrials 12.2%
5 Consumer Discretionary 11.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXPR
1151
DELISTED
Express, Inc.
EXPR
-12,096
Closed -$4.32M
MDRX
1152
DELISTED
Veradigm Inc. Common Stock
MDRX
-84,563
Closed -$1.05M
CHS
1153
DELISTED
Chicos FAS, Inc.
CHS
-150,601
Closed -$2.37M
NETI
1154
DELISTED
Eneti Inc.
NETI
-2,516
Closed -$410K
SGEN
1155
DELISTED
Seagen Inc. Common Stock
SGEN
-101,439
Closed -$3.91M
NM
1156
DELISTED
Navios Maritime Holdings Inc.
NM
-7,870
Closed -$196K
ICPT
1157
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-7,900
Closed -$1.31M
AVID
1158
DELISTED
Avid Technology Inc
AVID
-10,686
Closed -$85K
MMP
1159
DELISTED
Magellan Midstream Partners, L.P.
MMP
-27,827
Closed -$1.67M
BKI
1160
DELISTED
Black Knight, Inc. Common Stock
BKI
-10,133
Closed -$330K
DCP
1161
DELISTED
DCP Midstream, LP
DCP
-86,720
Closed -$2.1M
LCI
1162
DELISTED
Lannett Company, Inc.
LCI
-33,778
Closed -$5.61M
TTM
1163
DELISTED
Tata Motors Limited
TTM
-69,447
Closed -$1.56M
CLVS
1164
DELISTED
Clovis Oncology, Inc.
CLVS
-8,208
Closed -$755K
STON
1165
DELISTED
StoneMor Inc.
STON
-27,396
Closed -$747K
CCXI
1166
DELISTED
ChemoCentryx, Inc.
CCXI
-282,713
Closed -$1.71M
MNDT
1167
DELISTED
Mandiant, Inc. Common Stock
MNDT
-36,000
Closed -$1.15M
EPZM
1168
DELISTED
Epizyme, Inc
EPZM
-133,714
Closed -$1.72M
NP
1169
DELISTED
Neenah, Inc. Common Stock
NP
-28,059
Closed -$1.64M
ECOL
1170
DELISTED
US Ecology, Inc.
ECOL
-5,555
Closed -$242K
RDS.A
1171
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
-35,475
Closed -$1.59M
RDS.B
1172
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
-16,891
Closed -$802K
CXP
1173
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
-20,768
Closed -$482K
CVA
1174
DELISTED
Covanta Holding Corporation
CVA
-410,438
Closed -$7.16M
FLXN
1175
DELISTED
Flexion Therapeutics, Inc.
FLXN
-132,945
Closed -$1.98M

Similar funds

Marshall Wace's Q4 2015 Portfolio in Review

As of Q4 2015, Marshall Wace held 1,276 positions worth $10.7B, up 31% from $8.14B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Marshall Wace deployed $2.21B of net new capital in Q4 2015, opening 389 new positions and adding to 311 existing holdings. Its largest new stake was The Mosaic Company: 1,613,517 shares worth $44.5M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was Sherwin-Williams, an estimated $73.7M trimmed.

  • Marshall Wace's largest Q4 2015 buy was The Mosaic Company: 1,613,517 shares worth $44.5M.
  • Marshall Wace added most to Bristol-Myers Squibb in Q4 2015, an estimated $119M increase.
  • Marshall Wace's biggest Q4 2015 reduction was Sherwin-Williams, cutting an estimated $73.7M.
  • Marshall Wace fully exited HOME PROPERTIES, INC in Q4 2015, selling an estimated $40.2M.
  • Marshall Wace's ten largest holdings make up 17% of its $10.7B portfolio in Q4 2015.
  • Marshall Wace opened 389 new positions and closed 325 in Q4 2015.
  • Marshall Wace's portfolio value rose 31% quarter-over-quarter to $10.7B.

Based on Marshall Wace's 13F filing for Q4 2015, filed 10 Feb 2016.